Thyroid Drugs Part 4 PDF
Document Details
Uploaded by leichnam
Emory & Henry College
Tags
Summary
This document provides information on hyperthyroidism, including causes, symptoms, diagnostic tests, and treatment options. It includes questions and answers related to the management of hyperthyroidism, and is likely part of medical education materials or notes.
Full Transcript
\#\#\# \*\*Slide 19: Hyperthyroidism - Overview\*\* 1\. \*\*Which of the following is the most common cause of hyperthyroidism?\*\* \- A. Thyroid cancer \- B. Graves\' disease \- C. Toxic multinodular goiter \- D. Drug-induced thyroiditis \*\*Answer:\*\* B. Graves\' disease 2\. \*\*Which lab...
\#\#\# \*\*Slide 19: Hyperthyroidism - Overview\*\* 1\. \*\*Which of the following is the most common cause of hyperthyroidism?\*\* \- A. Thyroid cancer \- B. Graves\' disease \- C. Toxic multinodular goiter \- D. Drug-induced thyroiditis \*\*Answer:\*\* B. Graves\' disease 2\. \*\*Which lab finding is typical in hyperthyroidism?\*\* \- A. Elevated TSH \- B. Suppressed TSH, elevated T3 and T4 \- C. Decreased T3 and T4 levels \- D. Elevated reverse T3 \*\*Answer:\*\* B. Suppressed TSH, elevated T3 and T4 3\. \*\*Which symptom is characteristic of hyperthyroidism?\*\* \- A. Cold intolerance \- B. Bradycardia \- C. Heat intolerance \- D. Weight gain \*\*Answer:\*\* C. Heat intolerance \-\-- \#\#\# \*\*Slide 20: Graves\' Disease\*\* 1\. \*\*What is the primary immunologic feature of Graves\' disease?\*\* \- A. Production of thyroid-stimulating antibodies (TSI) \- B. Production of anti-thyroid peroxidase antibodies \- C. Decreased iodine uptake \- D. Destruction of thyroid follicular cells \*\*Answer:\*\* A. Production of thyroid-stimulating antibodies (TSI) 2\. \*\*Which eye-related condition is associated with Graves\' disease?\*\* \- A. Ptosis \- B. Orbital myositis \- C. Exophthalmos \- D. Optic neuritis \*\*Answer:\*\* C. Exophthalmos 3\. \*\*Which test can be used to confirm the diagnosis of Graves\' disease?\*\* \- A. Anti-thyroid peroxidase antibodies \- B. Radioactive iodine uptake (RAIU) test \- C. Serum cortisol levels \- D. Thyroid ultrasound \*\*Answer:\*\* B. Radioactive iodine uptake (RAIU) test \-\-- \#\#\# \*\*Slide 21: Treatment of Hyperthyroidism\*\* 1\. \*\*Which of the following is a first-line treatment for hyperthyroidism?\*\* \- A. Methimazole \- B. Propylthiouracil (PTU) \- C. Levothyroxine \- D. Liothyronine \*\*Answer:\*\* A. Methimazole 2\. \*\*Which of the following hyperthyroid treatments is contraindicated in the first trimester of pregnancy?\*\* \- A. Radioactive iodine \- B. Methimazole \- C. Propylthiouracil (PTU) \- D. Beta-blockers \*\*Answer:\*\* B. Methimazole 3\. \*\*What is the primary action of thioamide drugs (e.g., methimazole, PTU) in treating hyperthyroidism?\*\* \- A. Block thyroid hormone release \- B. Inhibit thyroid hormone synthesis \- C. Increase iodine uptake by the thyroid \- D. Decrease peripheral conversion of T4 to T3 \*\*Answer:\*\* B. Inhibit thyroid hormone synthesis \-\-- \#\#\# \*\*Slide 22: Methimazole and Propylthiouracil (PTU)\*\* 1\. \*\*Methimazole is preferred over PTU due to which of the following advantages?\*\* \- A. Lower incidence of side effects \- B. Safer for use during pregnancy \- C. Longer half-life and once-daily dosing \- D. Better efficacy for treating thyroid cancer \*\*Answer:\*\* C. Longer half-life and once-daily dosing 2\. \*\*Which of the following is a serious side effect of PTU?\*\* \- A. Hepatotoxicity \- B. Hyperkalemia \- C. Osteoporosis \- D. Nephrotoxicity \*\*Answer:\*\* A. Hepatotoxicity 3\. \*\*In what situation is PTU preferred over methimazole?\*\* \- A. During the first trimester of pregnancy \- B. In patients with liver disease \- C. In patients with renal failure \- D. For long-term therapy in children \*\*Answer:\*\* A. During the first trimester of pregnancy \-\-- \#\#\# \*\*Slide 23: Radioactive Iodine Therapy\*\* 1\. \*\*Which of the following is a common side effect of radioactive iodine therapy for hyperthyroidism?\*\* \- A. Hypothyroidism \- B. Hypercalcemia \- C. Weight gain \- D. Hyperkalemia \*\*Answer:\*\* A. Hypothyroidism 2\. \*\*Which patient population should avoid radioactive iodine therapy?\*\* \- A. Men with prostate cancer \- B. Women who are pregnant or breastfeeding \- C. Children under 18 years of age \- D. Patients with autoimmune disorders \*\*Answer:\*\* B. Women who are pregnant or breastfeeding 3\. \*\*How long should a patient wait to conceive after receiving radioactive iodine therapy?\*\* \- A. 1 month \- B. 3 months \- C. 6 months \- D. 12 months \*\*Answer:\*\* C. 6 months \-\-- \#\#\# \*\*Slide 24: Beta-blockers in Hyperthyroidism\*\* 1\. \*\*What is the primary use of beta-blockers in the treatment of hyperthyroidism?\*\* \- A. Reduce thyroid hormone production \- B. Alleviate symptoms such as tachycardia and tremors \- C. Block iodine uptake \- D. Inhibit thyroid-stimulating antibodies \*\*Answer:\*\* B. Alleviate symptoms such as tachycardia and tremors 2\. \*\*Which beta-blocker is most commonly used in the management of hyperthyroid symptoms?\*\* \- A. Propranolol \- B. Metoprolol \- C. Atenolol \- D. Labetalol \*\*Answer:\*\* A. Propranolol 3\. \*\*In addition to reducing heart rate, how do beta-blockers assist in hyperthyroidism management?\*\* \- A. Increase T4 production \- B. Decrease TSH secretion \- C. Block peripheral conversion of T4 to T3 \- D. Increase iodine uptake \*\*Answer:\*\* C. Block peripheral conversion of T4 to T3